Obituaries

Last Name

Wayne Fenton, 1953-2006 (PDF 52Kb)

Wayne Fenton, M.D., is best known for his 'behind the scenes' efforts at the NIMH to transform clinical research. In 2003, recognizing the cognitive deficits in schizophrenia and the largest source of disability for many patients, Fenton led landmark NIMH efforts targeting cognitive impairments for people with schizophrenia.

Solomon C. Goldberg, 1924-2007 (PDF 138Kb)

The research career and contributions of Solomon C. Goldberg, Ph.D., helped forge the field of clinical psychopharmacology clinical trials. His expertise in research methodology and statistics are reflected in the statistical techniques that he was often the first to use in clinical psychopharmacology and in the authorship of articles and chapters with biostatisticians.

Louis A. Gottschalk 1916-2008 (PDF 146Kb)

Dr. Gottschalk made national headlines in the late 1980s when he concluded that President Ronald Reagan suffered from cognitive brain impairment as early as his first term, years before the late president was diagnosed with Alzheimer’s.

Jack Peter Green, 1925-2007 (PDF 58Kb)

Jack Peter Green, M.D., Ph.D., was the founding chairperson of the Department of Pharmacology at Mount Sinai School of Medicine and led the department for almost 30 years. Dr. Green was among the first to recognize the multiple subtypes of serotonin receptors in the brain.

Gerard E. Hogarty, 1935-2006 (PDF 51Kb)

Gerard E. Hogarty, M.S.W., is best known for developing four psychosocial treatment approaches specific to schizophrenia.

Murray E. Jarvik, 1923-2008 (PDF 225Kb)

Murray Jarvik was a founding member of ACNP. Murray was best known for his research on nicotine addiction and as a co-inventor of the nicotine patch to help people stop smoking.

Seymour Kaufman, 1924-2009 (PDF 173Kb)

In Dr. Kaufman's five years at New York University, he matured into an outstanding enzymologist and biochemist and made his first major contribution to biochemistry, the discovery of substrate phosphorylation in the conversion of a-ketoglutarate to succinate in the tricarboxylic acid cycle.

Ann E. Kelley, 1954-2007 (PDF 57Kb)

Dr. Ann E. Kelley led an eminent career in which she made groundbreaking contributions to neuropsychopharmacology. Importantly, Dr. Kelley was a pioneer for women in science and launched the successful careers of a generation of neuroscientists through her mentoring and teaching.

Eva King Killam, 1920-2006 (PDF 54Kb)

Eva King Killam, Ph.D., was a founding member of the ACNP and the first female President. Her research focused on the effects and actions of drugs on the brainstem and reticular formation.

Roland Kuhn, 1912-2005 (PDF 55Kb)

Roland Kuhn, M.D., the discoverer in 1956 of the antidepressant effect of imipramine, died October 10, 2005, at the age of 93.

Albert Kurland (PDF 78Kb)

Dr. Albert Kurland was the founder of the Maryland State Psychiatric Research Center and an eternal optimist who worked energetically and never said an unkind word about anyone.

User Name:
Password:

Forgot your user name or password?
Remember me.